Literature DB >> 21225418

Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats.

Bhupesh Sharma1, Nirmal Singh.   

Abstract

RATIONALE: Vascular dementia is the second leading cause of dementia, which is strongly associated with diabetes. Diabetes and dementia have become a major public health concern worldwide. At this point of time, it is very important to find the possible pharmacological agents which may be useful in management and therapy of dementia including Alzheimer's disease, vascular dementia, etc.
OBJECTIVES: To investigate the effect of sodium butyrate on streptozotocin (STZ) diabetes induced vascular dementia in rats.
METHODS: Diabetes and subsequent endothelial dysfunction and dementia were induced in rats by administration of single dose of STZ. Drug treatment was started after 1 month of STZ administration and treatment was continued until the end of the study. Morris water maze (MWM) test was employed for testing learning and memory. Endothelial function was measured on isolated aortic rings using student physiograph. Serum glucose, body weight, serum nitrite/nitrate, aortic superoxide anion generation, brain thiobarbituric acid reactive species (TBARS), reduced glutathione (GSH) levels, and acetylcholinesterase activity were also tested.
RESULTS: STZ treatment produced endothelial dysfunction, impairment of learning and memory, reduction in body weight and serum nitrite/nitrate, and increase in serum glucose, aortic and brain oxidative stress (increased superoxide anion, TBARS, and decreased GSH levels), and brain acetylcholinesterase activity. Treatment of sodium butyrate attenuated diabetes induced impairment of learning, memory, endothelial function, and various biochemical parameters.
CONCLUSIONS: Sodium butyrate may be considered as potential pharmacological agent for the management of diabetes induced vascular dementia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21225418     DOI: 10.1007/s00213-011-2164-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  75 in total

1.  Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.

Authors:  Omana P Mathew; Kasturi Ranganna; Frank M Yatsu
Journal:  Biomed Pharmacother       Date:  2010-12       Impact factor: 6.529

2.  Improved method for the determination of blood glutathione.

Authors:  E BEUTLER; O DURON; B M KELLY
Journal:  J Lab Clin Med       Date:  1963-05

3.  Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain.

Authors:  Giuseppe Faraco; Tristano Pancani; Laura Formentini; Paolo Mascagni; Gianluca Fossati; Flavio Leoni; Flavio Moroni; Alberto Chiarugi
Journal:  Mol Pharmacol       Date:  2006-08-31       Impact factor: 4.436

4.  Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition.

Authors:  Yongqing Li; Zengqiang Yuan; Baoling Liu; Elizabeth A Sailhamer; Christian Shults; George C Velmahos; Marc Demoya; Hasan B Alam
Journal:  J Trauma       Date:  2008-04

5.  Protective effect of a poly-phytocompound on early stage nephropathy secondary to experimentally-induced diabetes.

Authors:  F Marotta; M Harada; E D Dallah; H Yadav; U Solimene; S Di Lembo; E Minelli; S Jain; D H Chui
Journal:  J Biol Regul Homeost Agents       Date:  2010 Jan-Mar       Impact factor: 1.711

6.  Red cell and plasma cholinesterase activities in microsamples of human and animal blood determined simultaneously by a modified acetylthiocholine-DTNB procedure.

Authors:  G Voss; K Sachsse
Journal:  Toxicol Appl Pharmacol       Date:  1970-05       Impact factor: 4.219

Review 7.  Alzheimer's disease and endothelial dysfunction.

Authors:  Giuseppe Bomboi; Lorenzo Castello; Francesco Cosentino; Franco Giubilei; Francesco Orzi; Massimo Volpe
Journal:  Neurol Sci       Date:  2009-10-17       Impact factor: 3.307

8.  HDAC2 negatively regulates memory formation and synaptic plasticity.

Authors:  Ji-Song Guan; Stephen J Haggarty; Emanuela Giacometti; Jan-Hermen Dannenberg; Nadine Joseph; Jun Gao; Thomas J F Nieland; Ying Zhou; Xinyu Wang; Ralph Mazitschek; James E Bradner; Ronald A DePinho; Rudolf Jaenisch; Li-Huei Tsai
Journal:  Nature       Date:  2009-05-07       Impact factor: 49.962

9.  Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats.

Authors:  Rajeshkumar U Koladiya; Amteshwar S Jaggi; Nirmal Singh; Bhupesh K Sharma
Journal:  BMC Pharmacol       Date:  2008-08-09

10.  The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses.

Authors:  José Manuel Afonso Moreira; Peter Scheipers; Poul Sørensen
Journal:  BMC Cancer       Date:  2003-11-09       Impact factor: 4.430

View more
  16 in total

1.  Silymarin ameliorates memory deficits and neuropathological changes in mouse model of high-fat-diet-induced experimental dementia.

Authors:  Amit Kumar; Amteshwar S Jaggi; Rupinder K Sodhi; Nirmal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-05-28       Impact factor: 3.000

2.  Adenosine monophosphate-activated protein kinase activation mediates the leptin-induced attenuation of cognitive impairment in a streptozotocin-induced rat model.

Authors:  Bin Zhu; Ri-Yue Jiang; Chun Yang; Ning Liu
Journal:  Exp Ther Med       Date:  2015-02-25       Impact factor: 2.447

3.  Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats.

Authors:  Bhupesh Sharma; Nirmal Singh
Journal:  Psychopharmacology (Berl)       Date:  2012-04-20       Impact factor: 4.530

4.  Habitat degradation impacts black howler monkey (Alouatta pigra) gastrointestinal microbiomes.

Authors:  Katherine R Amato; Carl J Yeoman; Angela Kent; Nicoletta Righini; Franck Carbonero; Alejandro Estrada; H Rex Gaskins; Rebecca M Stumpf; Suleyman Yildirim; Manolito Torralba; Marcus Gillis; Brenda A Wilson; Karen E Nelson; Bryan A White; Steven R Leigh
Journal:  ISME J       Date:  2013-03-14       Impact factor: 10.302

5.  In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.

Authors:  Prabhat Singh; Bhupesh Sharma; Surbhi Gupta; B M Sharma
Journal:  Psychopharmacology (Berl)       Date:  2014-07-26       Impact factor: 4.530

6.  Novel Combinatorial Therapeutic Targeting of PAI-1 (SERPINE1) Gene Expression in Alzheimer's Disease.

Authors:  Stacie M Kutz; Craig E Higgins; Paul J Higgins
Journal:  Mol Med Ther       Date:  2012-12-13

7.  Use of sodium butyrate as an alternative to dietary fiber: effects on the embryonic development and anti-oxidative capacity of rats.

Authors:  Yan Lin; Zheng-feng Fang; Lian-qiang Che; Sheng-yu Xu; De Wu; Cai-mei Wu; Xiu-qun Wu
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

8.  Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats.

Authors:  Gehan S Georgy; Noha N Nassar; Hanaa A Mansour; Dalaal M Abdallah
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

9.  Ameliorative Effect of a Selective Endothelin ETA Receptor Antagonist in Rat Model of L-Methionine-induced Vascular Dementia.

Authors:  Gautamjeet S Mangat; Amteshwar S Jaggi; Nirmal Singh
Journal:  Korean J Physiol Pharmacol       Date:  2014-06-12       Impact factor: 2.016

10.  Neuroprotective effect of resveratrol in diabetic cerebral ischemic-reperfused rats through regulation of inflammatory and apoptotic events.

Authors:  Hoda E Mohamed; Sahar E El-Swefy; Rehab A Hasan; Ahmed A Hasan
Journal:  Diabetol Metab Syndr       Date:  2014-08-17       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.